Close

Array Biopharma (ARRY), Pierre Fabre Announce Presentation of Binimetinib Combo Phase 3 Data in BRAF-Mutant Melanoma

Go back to Array Biopharma (ARRY), Pierre Fabre Announce Presentation of Binimetinib Combo Phase 3 Data in BRAF-Mutant Melanoma